Healthcare provider profile · identity verified

Daniel M. Sappenfield, MD

Family Practice · CHARLOTTE, NC · NPI 1346275955

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	866	256
Amlodipine Besylate	Amlodipine Besylate	482	139
Levothyroxine Sodium	Levothyroxine Sodium	354	99
Lisinopril	Lisinopril	287	97
Omeprazole	Omeprazole	281	81
Metoprolol Succinate	Metoprolol Succinate	243	69
Gabapentin	Gabapentin	225	66
Metformin Hcl Er	Metformin Hcl	218	63
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	215	66
Losartan Potassium	Losartan Potassium	214	64
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	207	61
Rosuvastatin Calcium	Rosuvastatin Calcium	191	59
Trazodone Hcl	Trazodone Hcl	166	48
Tamsulosin Hcl	Tamsulosin Hcl	163	49
Simvastatin	Simvastatin	161	42
Metformin Hcl	Metformin Hcl	156	50
Pantoprazole Sodium	Pantoprazole Sodium	154	53
Pravastatin Sodium	Pravastatin Sodium	151	40
Escitalopram Oxalate	Escitalopram Oxalate	142	46
Meloxicam	Meloxicam	131	41
Hydrochlorothiazide	Hydrochlorothiazide	125	42
Montelukast Sodium	Montelukast Sodium	111	29
Famotidine	Famotidine	107	34
Fluticasone Propionate	Fluticasone Propionate	107	49
Allopurinol	Allopurinol	103	29
Glimepiride	Glimepiride	98	29
Fluoxetine Hcl	Fluoxetine Hcl	94	22
Metoprolol Tartrate	Metoprolol Tartrate	91	22
Sertraline Hcl	Sertraline Hcl	91	32
Carvedilol	Carvedilol	88	31
Diclofenac Sodium	Diclofenac Sodium	78	29
Duloxetine Hcl	Duloxetine Hcl	73	23
Mounjaro	Tirzepatide	69	13
Alprazolam	Alprazolam	67	20
Potassium Chloride	Potassium Chloride	66	21
Albuterol Sulfate Hfa	Albuterol Sulfate	64	27
Furosemide	Furosemide	61	21
Tramadol Hcl	Tramadol Hcl	60	15
Prednisone	Prednisone	58	52
Clopidogrel	Clopidogrel Bisulfate	57	16
Alendronate Sodium	Alendronate Sodium	54	18
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	53	18
Chlorthalidone	Chlorthalidone	50	12
Pioglitazone Hcl	Pioglitazone Hcl	50	16
Warfarin Sodium	Warfarin Sodium	50	suppressed
Clonazepam	Clonazepam	48	suppressed
Eliquis	Apixaban	47	18
Lovastatin	Lovastatin	47	13
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Citalopram Hbr	Citalopram Hydrobromide	38	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	38	13
Janumet	Sitagliptin Phos/Metformin Hcl	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	13
Xarelto	Rivaroxaban	36	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Finasteride	Finasteride	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	28
Spironolactone	Spironolactone	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Ipratropium Bromide	Ipratropium Bromide	31	suppressed
Ozempic	Semaglutide	31	suppressed
Ramipril	Ramipril	31	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	30	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Atenolol	Atenolol	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Celecoxib	Celecoxib	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	11
Baclofen	Baclofen	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	23	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	22
Wixela Inhub	Fluticasone Propion/Salmeterol	23	suppressed
Methylprednisolone	Methylprednisolone	21	21
Silodosin	Silodosin	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Ondansetron Odt	Ondansetron	18	15
Jardiance	Empagliflozin	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Glipizide	Glipizide	15	suppressed
Nystatin	Nystatin	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Diazepam	Diazepam	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Cholestyramine Light	Cholestyramine	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Trintellix	Vortioxetine Hydrobromide	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Euthyrox	Levothyroxine Sodium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error